Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “de Novo Liver Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00332462
What this trial is testing

Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 34
Large-scale testing (Phase 3)Study completedNCT03241043
What this trial is testing

Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Universitätsklinikum Hamburg-Eppendorf 20
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Testing effectiveness (Phase 2)Study completedNCT01614665
What this trial is testing

Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

Who this might be right for
Heart TransplantationKidney TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 44
Post-approval studies (Phase 4)Study completedNCT01371331
What this trial is testing

Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

Who this might be right for
Kidney TransplantationHeart TransplantationLiver Transplantation
Astellas Pharma Europe Ltd. 52
Testing effectiveness (Phase 2)Study completedNCT01146808
What this trial is testing

Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver

Who this might be right for
Hepatitis BLiver Transplantation
Columbia University 16
Large-scale testing (Phase 3)Study completedNCT00328770
What this trial is testing

De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Liver Carcinoma
University of Alberta 70
Post-approval studies (Phase 4)Active Not RecruitingNCT04720326
What this trial is testing

Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients

Who this might be right for
Prophylaxis Against Liver Transplant Rejection
Edward Geissler 268
Post-approval studies (Phase 4)Study completedNCT05153915
What this trial is testing

Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

Who this might be right for
Liver TransplantationKidney Transplantation
Astellas Pharma China, Inc. 56
Not applicableStudy completedNCT05492617
What this trial is testing

Early Detection of de Novo Cancer in Liver Transplant Recipients

Who this might be right for
De Novo CancerLiver Transplant Disorder
Rigshospitalet, Denmark 3,628
Large-scale testing (Phase 3)Study completedNCT00719745
What this trial is testing

Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Astellas Pharma Inc 74
Large-scale testing (Phase 3)Study completedNCT00378014
What this trial is testing

Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 276
Large-scale testing (Phase 3)Study completedNCT01625377
What this trial is testing

A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplantation
Novartis Pharmaceuticals 188
Post-approval studies (Phase 4)Study completedNCT00149994
What this trial is testing

Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 171
Early research (Phase 1)Study completedNCT00545259
What this trial is testing

Pharmacokinetic Study of AEB071 in Patients Following Liver Transplantation

Who this might be right for
de Novo Liver Transplantation
Novartis 13
Large-scale testing (Phase 3)Study completedNCT02040584
What this trial is testing

A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

Who this might be right for
Liver Transplant
Novartis Pharmaceuticals 217
Testing effectiveness (Phase 2)Ended earlyNCT00555321
What this trial is testing

Belatacept in Liver Transplant Recipients

Who this might be right for
Immunosuppression in Solid Organ Transplant
Bristol-Myers Squibb 260
Large-scale testing (Phase 3)Study completedNCT00720408
What this trial is testing

Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

Who this might be right for
Liver TransplantationTransplantation ImmunologyHost vs Graft Reaction
Astellas Pharma Inc 48
Post-approval studies (Phase 4)Study completedNCT00538265
What this trial is testing

Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation

Who this might be right for
Liver Transplantation
University Hospital, Toulouse 100
Testing effectiveness (Phase 2)Ended earlyNCT03781414
What this trial is testing

Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

Who this might be right for
Liver Transplant Rejection
Novartis Pharmaceuticals 129
Next Page